Faculty Disclosures
An Update on Multiple Sclerosis Patient Care for Advanced Practice Providers
Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.
Faculty | Relationship Identified With: |
Fred D. Lublin, MD (Course Chair) | Consultant/Advisor: AbbVie Inc.; Amgen; Ardanza Biopharma; Autolus Limited; Avotres; Bristol Myers Squibb; Cognito Therapeutics; EMD Serono; Genentech, Inc.; Genzyme; ImmPACT Bio; Immunic Therapeutics; InnoCare Pharma; Kite Pharma; Neuralight; Novartis Pharmaceuticals Corporation; Roche AG; Sanofi; SetPoint Medical; Sudo Biosciences; Viatris Inc.; Zenas BioPharma Grant/Research Support: Bristol Myers Squibb; Novartis Pharmaceuticals Corporation Speaker’s Bureau: Sanofi Stock Options: Avotres; Neuralight |
Ali Bateman, MD | Nothing to disclose |
Patty Bobryk, MHS, PT, MSCS, ATP | Nothing to disclose |
Anthony Feinstein, MD, PhD | Speaker’s Bureau: Merck & Co., Inc.; Novartis Pharmaceuticals Corporation Book Royalties: Bloomsbury Publishing; Cambridge University Press; G Editions; Johns Hopkins University Press |
Mark S. Freedman, MD | Consultant/Advisor: Actelion Pharmaceuticals; Alexion Pharmaceuticals; Amgen; AstraZeneca; EMD Serono; Genentech, Inc.; Horizon Therapeutics; Janssen Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Roche AG; Sanofi Grant/Research Support: Sanofi Speaker’s Bureau: Novartis Pharmaceuticals Corporation; Roche AG |
Colleen Harris, MN, NP, MSCN, MSCS | Consultant/Advisor: Amgen; EMD Serono; Novartis Pharmaceuticals Corporation; Roche AG |
Carrie M. Hersh, DO | Consultant/Advisor: Alexion Pharmaceuticals; Amgen; Bristol Myers Squibb; EMD Serono; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Sanofi; TG Therapeutics, Inc. Grant/Research Support: Biogen; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation Speaker’s Bureau: Sanofi |
Kristen Krysko, MD | Consultant/Advisor: Bristol Myers Squibb; EMD Serono; Novartis Pharmaceuticals Corporation; Roche Grant/Research Support: Roche AG Adjudication Committee: Moderna |
Clyde Markowitz, MD | Consultant/Advisor: EMD Serono; Genentech, Inc.; Horizon Therapeutics; Immunic Therapeutics; Novartis Pharmaceuticals Corporation; Roche AG; TG Therapeutics, Inc. |
Ahmed Zayed Obeidat, MD, PhD | Consultant/Advisor: Alexion Pharmaceuticals; Amgen; Biogen; Bristol Myers Squibb; EMD Serono; Genentech, Inc.; Horizon Therapeutics; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Octave Bioscience; Roche AG; Sandoz; Sanofi; TG Therapeutics, Inc. Speaker’s Bureau: Alexion Pharmaceuticals; Amgen; AstraZeneca; Biogen; Bristol Myers Squibb; EMD Serono; Merck & Co., Inc.; Sanofi; TG Therapeutics, Inc. |
Amy Perrin Ross, APN, MSN, CNRN, MSCN | Consultant/Advisor: Alexion Pharmaceuticals; Amgen; Bristol Myers Squibb; EMD Serono; Novartis Pharmaceuticals Corporation; Roche AG; Sandoz; UCB S.A, Belgium |
Scott Newsome, DO, MSCS, FAAN, FANA | Consultant/Advisor: Genentech, Inc.; Novartis Pharmaceuticals Corporation; Roche AG; Sanofi; TG Therapeutics, Inc. Grant/Research Support: Biogen; Genentech, Inc.; Kyverna Therapeutics Inc.; Lundbeck; Roche AG; Sanofi |